東京科学大学 · 医歯学総合研究科 · 助教

研究キーワードCancer・Internal・medicine・Oncology・分子生物学・免疫学・血液内科学・腫瘍免疫

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients 2025.03; 16 (1): 140-162. ( DOI )2025
• Suguru Miyazawa, Hiroaki Ono, Hironari Yamashita, Daisuke Asano, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Satoru Aoyama, Naoya Ishibashi, Keiichi Akahoshi, Sadakatsu Ikeda, Minoru Tanabe. Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasms. PLoS One. 2025.08; 20 (8): e0325727. ( PubMed , DOI )2025
• Tanaka H, Yoshida S, Aoyama S, Ikeda S, Kunieda J, Ohashi K, Fukuda S, Waseda Y, Tanaka H, Fujii Y. A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab. IJU case reports. 2024.09; 7 (5): 395-398. ( PubMed , DOI )2024
• Morikawa, R; Nitta, K; Yasuda, S; Kano, Y; Noji, R; Aoyama, S; Sato, S; Ikeda, S; Okamoto, R; Nagata, M; Mori, T; Suenaga, M. Identification of risk factors for gastrointestinal immune-related adverse events associated with immune check point inhibitors EXPERT OPINION ON DRUG SAFETY. 2024.12; 1-8. ( PubMed , DOI )2024

• 複数の抗原を認識し拡張性を高めたキメラ抗原受容体（CAR）-T細胞療法の開発
• 新規キメラ抗原受容体を用いた革新的ながん治療の開発

• 公式プロフィール
• ORCID